Skip to main content
. 2022 Aug 22;13:866189. doi: 10.3389/fendo.2022.866189

Table 1.

Comparison of the clinical characteristics between groups.

Group At baseline At 24 weeks
A(control) Sex 14(male/female:8/6) 14(male/female:8/6)
Age (years old) 53.40 ± 5.20 53.40 ± 5.20
BMI (kg/m2) 24.06 ± 2.85 23.85 ± 2.74
Waistline(cm) 83.0 ± 6.5 81 ± 6.87
B(sitagliptin) Sex 17(male/female:10/7) 17(male/female:10/7)
Age (years old) 54.40 ± 9.0 54.40 ± 9.40
BMI (kg/m2) 25.41 ± 3.45 24.39 ± 3.02※
Waistline(cm) 86.9 ± 9.8 84.88 ± 8.19※
C(metformin) Sex 17(male/female:9/8) 17(male/female:9/8)
Age (years old) 55.63 ± 10.9 55.63 ± 10.9
BMI (kg/m2) 26.46 ± 2.86 25.75 ± 3.55※
Waistline(cm) 88.50 ± 8.00 88.67 ± 8.80※
D(Sitagliptin+ metformin) Sex 20(male/female:9/11) 20(male/female:9/11)
Age (years old) 54.55 ± 6.6 54.55 ± 6.6
BMI (kg/m2) 26.07 ± 3.24 25.53 ± 3.02※
Waistline(cm) 90.0 ± 8.20 86.8 ± 6※

Self-pair comparison before and after treatment, ※P<0.05.

Data are number of patients or mean ± standard deviation.

BMI, body mass index.